Hypocalcaemia after intravenous bisphosphonateBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7453.1439-a (Published 10 June 2004) Cite this as: BMJ 2004;328:1439
Lesson to be learnt
- Cameron Fergus, specialist registrar in palliative medicine (firstname.lastname@example.org)
- Royal Infirmary of Edinburgh, Edinburgh EH3 9YW
EDITOR—Peter et al discuss the risk of hypocalcaemia after intravenous bisphosphonate.1 Case 4 of their series provides the opportunity for a further lesson to be learnt.
The patient in this case was given 90 mg pamidronate as treatment for hypercalcaemia of malignancy. A further 60 mg was …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial